Clinical Trials
5 trialsNCT00987636 2019-10-22
EWING2008
University Hospital Muenster
Phase 3 Completed
NCT01215344 2018-05-15
First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT01129336 2014-05-20
MACS1295
Novartis
Phase 4 Completed
NCT00091832 2014-01-28
Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer
Amgen
Phase 2 Completed
NCT00222053 2010-04-02
IFM 99-02 Thalidomide in Myeloma
University Hospital, Toulouse
Phase 3 Completed